Effect of TGF-β/Smad signaling pathway on lung myofibroblast differentiation

被引:0
|
作者
Li GU~2 Yuan-jue ZHU~(2
3 Genetic Laboratory of Development and Diseases
机构
关键词
myofibroblasts; transforming growth factorβ1; Smad;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
摘要
Aim:Myofibroblasts play important roles in the pathogenesis of lung fibrosis.Transforming growth factor(TGF)-β1has been widely recognized as a keyfibrogenic cytokine.The major signaling pathway of TGF--β1is through cytoplas-mic Smad proteins.Our study investigated the role of individual TGF--β1/Smadsignal proteins in mediating α-smooth muscle actin(α-SMA)gene expression,which is a well-known key marker of myofibroblast differentiation.Methods:Wetransiently cotransfected α-SMA promoter-luciferase fusion plasmid(p895-Luc)and Smad expression plasmids and measured Luc activity in TGF--β1-treated hu-man fetal lung fibroblasts.We induced Smad3 knockout mice lung fibrosis bybleomycin,α-SMA protein expression was assessed by Western blotting.Col-lagen protein was analyzed by measuring hydroxyprolin.Myofibroblast morphol-ogy was assessed by immunohistochemistry.Results:We found that theoverexpression of Smad3,not Smad2 markedly increased TGF--β1-induced α-SMApromoter activity and α-SMA protein expression in vitro,whereas the over-expression of dominant negative mutant Smad3 and Smad7 repressed TGF--β1-induced α-SMA gene expression.Compared to wild-type mice,Smad3 knockoutmice showed attenuated lung fibrosis after bleomycin treatment,manifested bylower collagen production and myofibroblast differentiation.Conclusion:Ourstudy suggested TGF--β1/Smad3 is a major pathway which regulated themyofibroblast differentiation.This result indicates a potential significance forfuture attempts of attenuating the progression of human lung fibrosis by theinhibition of the Smad3 cascade.
引用
收藏
页码:382 / 391
页数:10
相关论文
共 50 条
  • [21] Cytoskeletal Signaling Mediates TGF-β1-induced Pulmonary Myofibroblast Differentiation
    Sandbo, N.
    Lau, A.
    Kregel, S.
    Kach, J.
    Yau, D.
    Dulin, N. O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [22] CYTOSKELETAL SIGNALING MEDIATES TGF-β1-INDUCED PULMONARY MYOFIBROBLAST DIFFERENTIATION
    Sandbo, N.
    Lau, A.
    Kregel, S.
    Yau, D.
    Kach, J.
    Dulin, N.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (04) : 671 - 671
  • [23] Adrenomedullin Ameliorates Pulmonary Fibrosis by Regulating TGF-β-Smads Signaling and Myofibroblast Differentiation
    Wei, Yangxuan
    Tanaka, Megumu
    Sakurai, Takayuki
    Kamiyoshi, Akiko
    Ichikawa-Shindo, Yuka
    Kawate, Hisaka
    Cui, Nanqi
    Kakihara, Shinji
    Zhao, Yunlu
    Aruga, Kohsuke
    Sanjo, Hideki
    Shindo, Takayuki
    ENDOCRINOLOGY, 2021, 162 (08)
  • [24] ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway
    Yuan, Qiuhuan
    Cao, Shengchuan
    Dong, Qianqian
    Wang, Zheng
    Xu, Youshun
    Han, Qi
    Ma, Jingling
    Wei, Shujian
    Pang, Jiaojiao
    Yang, Feihong
    Zhang, Rui
    Liu, Baoshan
    Dai, Shuai
    Xue, Li
    Wang, Jiali
    Xue, Mengyang
    Xu, Tonghui
    Zheng, Wen
    Xu, Feng
    Chen, Yuguo
    Guo, Ping
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 73 (04) : 248 - 256
  • [25] TGF-β1-mediated fibroblast-myofibroblast terminal differentiation -: the role of Smad proteins
    Evans, RA
    Tian, YC
    Steadman, R
    Phillips, AO
    EXPERIMENTAL CELL RESEARCH, 2003, 282 (02) : 90 - 100
  • [26] TGF-β PRODUCTION AND MYOFIBROBLAST DIFFERENTIATION IN CYSTIC FIBROSIS
    Harris, W. T.
    Nicola, T.
    Macewen, M.
    Li, Y.
    Ambalavanan, N.
    Clancy, J. P.
    PEDIATRIC PULMONOLOGY, 2011, : 276 - 277
  • [27] Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway
    Yingwen Bai
    Lulu Wang
    Lingyun TingYang
    Weihong Wang
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 2379 - 2391
  • [28] Systematic analysis of the TGF-β-Smad signaling pathway in gastrointestinal cancer cells
    Ijichi, H
    Ikenoue, T
    Kato, N
    Mitsuno, Y
    Togo, G
    Kato, J
    Kanai, F
    Shiratori, Y
    Omata, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (02) : 350 - 357
  • [29] Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway
    Bai, Yingwen
    Wang, Lulu
    Yang, Ting
    Wang, Lingyun
    Ge, Weihong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (10) : 2379 - 2391
  • [30] The effect of a novel TGF-β inhibitor on TGF-β/Smad signaling in normal dermal fibroblasts.
    Mori, Y
    Ishida, W
    Bhattacharyya, S
    Varga, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S479 - S479